These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32533104)

  • 21. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F
    Bull Acad Natl Med; 2007 Feb; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and molecular findings of 38 Iranian patients with chronic granulomatous disease caused by p47-phox defect.
    Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Bazargan N; Movahedi M; Mahlouji Rad M; Mahdaviani SA; Mamishi S; Khotaei GT; Mansouri D; Zandieh F; Pourpak Z
    Scand J Immunol; 2019 Jul; 90(1):e12767. PubMed ID: 30963593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
    Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
    J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioluminescence imaging of NADPH oxidase activity in different animal models.
    Han W; Li H; Segal BH; Blackwell TS
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23117583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease.
    Roesler J; Curnutte JT; Rae J; Barrett D; Patino P; Chanock SJ; Goerlach A
    Blood; 2000 Mar; 95(6):2150-6. PubMed ID: 10706888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
    Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
    Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, Immunological, and Molecular Findings of Patients with p47
    Kulkarni M; Desai M; Gupta M; Dalvi A; Taur P; Terrance A; Bhat S; Manglani M; Raj R; Shah I; Madkaikar M
    J Clin Immunol; 2016 Nov; 36(8):774-784. PubMed ID: 27699571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
    Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
    Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-scan method for the recognition of carriers and patients with p47(phox)-deficient autosomal recessive chronic granulomatous disease.
    Dekker J; de Boer M; Roos D
    Exp Hematol; 2001 Nov; 29(11):1319-25. PubMed ID: 11698128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p47(phox) directs murine macrophage cell fate decisions.
    Yi L; Liu Q; Orandle MS; Sadiq-Ali S; Koontz SM; Choi U; Torres-Velez FJ; Jackson SH
    Am J Pathol; 2012 Mar; 180(3):1049-1058. PubMed ID: 22222227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic structure of the human p47-phox (NCF1) gene.
    Chanock SJ; Roesler J; Zhan S; Hopkins P; Lee P; Barrett DT; Christensen BL; Curnutte JT; Görlach A
    Blood Cells Mol Dis; 2000 Feb; 26(1):37-46. PubMed ID: 10772875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease.
    Segal BH; Sakamoto N; Patel M; Maemura K; Klein AS; Holland SM; Bulkley GB
    Infect Immun; 2000 Apr; 68(4):2374-8. PubMed ID: 10722648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer.
    Thrasher A; Chetty M; Casimir C; Segal AW
    Blood; 1992 Sep; 80(5):1125-9. PubMed ID: 1325210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.